China National Medicines Corp Ltd - Asset Resilience Ratio

Latest as of December 2021: 0.04%

China National Medicines Corp Ltd (600511) has an Asset Resilience Ratio of 0.04% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of China National Medicines Corp Ltd for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥11.40 Million

≈ $1.67 Million USD Cash + Short-term Investments

Total Assets

CN¥27.48 Billion

≈ $4.02 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2004–2021)

This chart shows how China National Medicines Corp Ltd's Asset Resilience Ratio has changed over time. See net assets of China National Medicines Corp Ltd for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down China National Medicines Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600511 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥11.40 Million	0.04%
Total Liquid Assets	CN¥11.40 Million	0.04%

Asset Resilience Insights

Limited Liquidity: China National Medicines Corp Ltd maintains only 0.04% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

China National Medicines Corp Ltd Industry Peers by Asset Resilience Ratio

Compare China National Medicines Corp Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Mayne Pharma Group Ltd AU:MYX	Medical Distribution	4.00%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	Medical Distribution	4.44%
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd SHG:600332	Medical Distribution	5.56%

Annual Asset Resilience Ratio for China National Medicines Corp Ltd (2004–2021)

The table below shows the annual Asset Resilience Ratio data for China National Medicines Corp Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	0.04%	CN¥11.40 Million ≈ $1.67 Million	CN¥27.48 Billion ≈ $4.02 Billion	+0.03pp
2004-12-31	0.02%	CN¥183.50K ≈ $26.85K	CN¥1.19 Billion ≈ $174.55 Million	--

pp = percentage points

About China National Medicines Corp Ltd

SHG:600511 China Medical Distribution

Market Cap

$3.16 Billion

CN¥21.62 Billion CNY

Market Cap Rank

#4776 Global

#884 in China

Share Price

CN¥28.66

Change (1 day)

-0.24%

52-Week Range

CN¥28.06 - CN¥31.21

All Time High

CN¥57.66